MENU
+Compare
PRPO
Stock ticker: NASDAQ
AS OF
Nov 25 closing price
Price
$22.28
Change
-$2.31 (-9.39%)
Capitalization
39.03M

PRPO Precipio Forecast, Technical & Fundamental Analysis

Precipio Inc is a healthcare solutions company focused on cancer diagnostics... Show more

Industry: #Biotechnology
PRPO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PRPO with price predictions
Nov 25, 2025

Momentum Indicator for PRPO turns positive, indicating new upward trend

PRPO saw its Momentum Indicator move above the 0 level on November 17, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PRPO just turned positive on November 18, 2025. Looking at past instances where PRPO's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

PRPO moved above its 50-day moving average on November 17, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where PRPO advanced for three days, in of 230 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 153 cases where PRPO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PRPO moved out of overbought territory on November 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 43 cases where PRPO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRPO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PRPO broke above its upper Bollinger Band on November 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.839) is normal, around the industry mean (12.399). P/E Ratio (0.000) is within average values for comparable stocks, (139.674). PRPO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.978). PRPO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (1.502) is also within normal values, averaging (9.896).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PRPO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRPO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
PRPO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of medical diagnostics services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4 Science Park
Phone
+1 203 787-7888
Employees
57
Web
https://www.precipiodx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BYDIF4.250.34
+8.70%
Byd Electronic International Co Ltd.
GNTA1.920.14
+7.87%
Genenta Science SpA
LOB32.171.64
+5.37%
Live Oak Bancshares
KNCAF2.90N/A
N/A
Konica Minolta Inc.
LPBB10.50N/A
N/A
Launch Two Acquisition Corp

PRPO and Stocks

Correlation & Price change

A.I.dvisor tells us that PRPO and VTAK have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRPO and VTAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRPO
1D Price
Change %
PRPO100%
-9.39%
VTAK - PRPO
27%
Poorly correlated
+12.13%
TNON - PRPO
27%
Poorly correlated
-1.74%
TIVC - PRPO
25%
Poorly correlated
+1.74%
INGN - PRPO
25%
Poorly correlated
+0.14%
XAIR - PRPO
25%
Poorly correlated
+4.69%
More